1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Family Planning & Abortion Clinics in the US - Industry Risk Rating Report

IBISWORLD INDUSTRY RISK RATINGS REPORT

This is the replacement for IBISWorld's August 2012 edition of Family Planning & Abortion Clinics in the US Industry Risk Ratings Report.

Industry Risk Ratings Synopsis

This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Family Planning & Abortion Clinics in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'.
The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk).
This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months.

Industry Definition

This industry includes freestanding centers with medical staff primarily engaged in assisting pregnant women and families in making various decisions regarding family planning. Services are provided on an outpatient basis and include contraception, genetic and prenatal counseling, voluntary sterilization and pregnancy termination.


Report Contents


Risk Overview
The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score.

Structural Risk
The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry's level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section.

Growth Risk
The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.

Sensitivity Risk
The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate.

Industry Risk and Industry Risk Scoring Methodology
This chapter provides an overview of how IBISWorld defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk.
Family Planning & Abortion Clinics in the US

Table Of Contents

Family Planning and Abortion Clinics in the US - Industry Risk Rating Report
RISK OVERVIEW
Industry Definition and Activities
Industry Risk Score
Risk Rating Analysis
STRUCTURAL RISK
Barriers to Entry
Basis of Competition
Domestic and International Markets
Industry Assistance
Life Cycle
Industry Volatility
GROWTH RISK
Growth Analysis

SENSITIVITY RISK
Marriage rate
Poverty rate
Federal funding for Medicare and Medicaid
Number of people with private health insurance
Technological change for the Generic Pharmaceutical Manufacturing industry
Regulation for the Family Planning and Abortion Clinics industry

IBISWORLD INDUSTRY RISK SCORING METHODOLOGY
What is Industry Risk?
Methodology
Risk Levels

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21 100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21 100
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7 500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.